On January 31st, the Total Product Expo (TPE24) tobacco exhibition will kick off in Las Vegas, Nevada. According to data from 2FIRSTS, the number of companies related to vaping participating in this exhibition exceeds 200. From the list of exhibitors, 2FIRSTS also noticed that the FDA Center for Tobacco Products, the direct regulatory agency for e-cigarettes in the United States, will also participate in this exhibition. Their booth number is 10176, located in the e-cigarette pavilion.
According to past experiences, regulatory authorities from countries such as Italy, Germany, and Indonesia have participated in e-cigarette exhibitions. These regulatory bodies generally adopt two types of participation. One way is similar to how the FDA participated in TPE24, by setting up exhibition booths to closely observe market trends and conduct regulatory publicity activities. Another way is without having an exhibition booth, but they would enter the exhibition to conduct inspections. In such cases, on-site law enforcement is usually carried out to crack down on illegal e-cigarettes and related products.
Currently, it is unclear what the specific purpose of FDA's participation in the exhibition is. However, 2FIRSTS will closely monitor the event and promptly report relevant information to our readers.
In addition, after the exhibition, 2FIRSTS will be hosting a deep sharing session on the the TPE Exhibition and US market on February 6th. During this event, the global executive editor-in-chief of 2FIRSTS, Yuna Hou, and the US team will be sharing the latest discoveries from the exhibition, delving into the trends of American products and policy directions. To find out more information and register, please scan the QR code below to contact the 2FIRSTS staff.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
![[Breaking] Juul’s Device and 4 Pod Products Officially Authorized by FDA, Reenters the U.S. Regulated Market](https://static.2firsts.com/uploads/20241113/34ffc17feb2b6076367c9e5f413641f2.jpg?x-oss-process=style/origin)
